RPL22 encodes Ribosomal Protein L22, a component of the large (60S) ribosomal subunit. RPL22 is conserved across eukaryotes and is essential for ribosome stability and function [@structure2010]. Beyond its structural role in the ribosome, RPL22 has been implicated in various cellular processes including:
Regulation of host cell translation during viral infection [@rpl2011]
Modulation of p53 activity and cellular stress responses [@ribosomal2010]
Control of hematopoietic stem cell function [@rpl2014]
Role in Neurodegeneration
Alzheimer's Disease
RPL22 expression is altered in Alzheimer's disease (AD) brains. Studies have demonstrated that ribosomal protein dysregulation, including RPL22, contributes to the characteristic translational deficits observed in AD neurons [@translational2011]. The impairment of protein synthesis affects synaptic plasticity and neuronal function.
RPL22 encodes Ribosomal Protein L22, a component of the large (60S) ribosomal subunit. RPL22 is conserved across eukaryotes and is essential for ribosome stability and function [@structure2010]. Beyond its structural role in the ribosome, RPL22 has been implicated in various cellular processes including:
Regulation of host cell translation during viral infection [@rpl2011]
Modulation of p53 activity and cellular stress responses [@ribosomal2010]
Control of hematopoietic stem cell function [@rpl2014]
Role in Neurodegeneration
Alzheimer's Disease
RPL22 expression is altered in Alzheimer's disease (AD) brains. Studies have demonstrated that ribosomal protein dysregulation, including RPL22, contributes to the characteristic translational deficits observed in AD neurons [@translational2011]. The impairment of protein synthesis affects synaptic plasticity and neuronal function.
Parkinson's Disease
In Parkinson's disease (PD), RPL22 has been identified as a modifier of alpha-synuclein toxicity. Research has shown that RPL22 haploinsufficiency increases neuronal vulnerability to alpha-synuclein aggregation, a central pathological feature of PD [@rpl2017].
RPL22 has been specifically implicated in FXTAS, a neurodegenerative disorder caused by premutation CGG repeats in the FMR1 gene. RPL22 binds to these expanded repeats and is sequestered into intranuclear inclusions, leading to ribosomal dysfunction [@rpl2007].
Ribosomal Protein Sequestration
A key mechanism in several neurodegenerative disorders involves the aberrant sequestration of ribosomal proteins:
FXTAS: RPL22 is one of several ribosomal proteins sequestered into neuronal intranuclear inclusions in FXTAS [@molecular2012]
Myotonic Dystrophy Type 1: Similar sequestration of ribosomal proteins occurs [@rna2016]
Aging Brain: Age-related changes in ribosomal protein localization contribute to cognitive decline [@aging2013]
Expression in Brain
RPL22 shows region-specific expression in the brain:
High expression in cerebral cortex
Moderate expression in hippocampus
Detectable expression in basal ganglia
Cerebellar expression in Purkinje cells
Therapeutic Relevance
Understanding RPL22's role in neurodegeneration has led to therapeutic strategies:
RNA-Binding Drug Development: Compounds that prevent RPL22 sequestration are under investigation [@rnatargeting2020]
Gene Expression Modulators: Strategies to restore ribosomal protein homeostasis [@restoring2014]
Viral Vector Approaches: Gene therapy to deliver functional RPL22 [@gene2021]